The impact of inflammation on the pathogenesis and prognosis of ischemic stroke

Journal of the Neurological Sciences

Volumn 271, Issue 1-2, 2008, Pages 104-109

  Nakase, Taizen ^a   Yamazaki, Takashi ^a   Ogura, Naoko ^a   Suzuki, Akifumi ^a   Nagata, Ken ^a  

^a RESEARCH INSTITUTE FOR BRAIN AND BLOOD VESSELS AKITA   (Japan)

Author keywords

C reactive protein; IL 6; Inflammation; Oxidized LDL; Risk; Stroke; TNF

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

ACUTE-PHASE PROTEINS; ACUTE-PHASE REACTION; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRAIN INFARCTION; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; STROKE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 45849096086     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.03.020     Document Type: Article

References (13)

1. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
2. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
3. Rost N.S., Wolf P.A., Kase C.S., Kelly-Hayes M., Silbershatz H., Massaro J.M., et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: The Framingham Study. Stroke 32 (2001) 2575-2579
4. Cao J.J., Thach C., Manolio T.A., Psaty B.M., Kuller L.H., Chaves P.H., et al. C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: The Cardiovascular Health Study. Circulation 108 (2003) 166-170
5. Hashimoto H., Kitagawa K., Hougaku H., Shimizu Y., Sakaguchi M., Nagai Y., et al. C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation 104 (2001) 63-67
6. Aviles R.J., Martin D.O., Apperson-Hansen C., Houghtaling P.L., Rautaharju P., Kronmal R.A., et al. Inflammation as a risk factor for atrial fibrillation. Circulation 108 (2003) 3006-3010
7. Nakase T., Sohl G., Theis M., Willecke K., and Naus C.C. Increased apoptosis and inflammation after focal brain ischemia in mice lacking connexin43 in astrocytes. Am J Pathol 164 (2004) 2067-2075
8. Adams Jr. H.P., Bendixen B.H., Kappelle L.J., Biller J., Love B.B., Gordon D.L., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24 (1993) 35-41
9. Castillo J., and Rodriguez I. Biochemical changes and inflammatory response as markers for brain ischaemia: molecular markers of diagnostic utility and prognosis in human clinical practice. Cerebrovasc Dis 17 Suppl 1 (2004) 7-18
10. Caplan L.R. Intracranial branch atheromatous disease: a neglected, understudied, and underused concept. Neurology 39 (1989) 1246-1250
11. Fassbender K., Rossol S., Kammer T., Daffertshofer M., Wirth S., Dollman M., et al. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci 122 (1994) 135-139
12. Vila N., Castillo J., Davalos A., and Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 31 (2000) 2325-2329
13. Liu T., Clark R.K., McDonnell P.C., Young P.R., White R.F., Barone F.C., et al. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 25 (1994) 1481-1488